DexCare Closes $75M in Series C Funding, Led by ICONIQ Growth, to Accelerate Market Expansion of its Care Access Platform

Funding will Advance DexCare’s Product Portfolio of Innovation to help U.S. Healthcare Systems Capture Consumers, Manage Limited Resources, and Control Costs to Fuel Growth DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access. The new funding brings the total raised to $146 million, including two oversubscribed rounds closed in less than two years. “We’re just emerging from an unpredictable moment in history that cast a spotlight on a strained U.S. healthcare system,” said Derek Streat, CEO at DexCare. “The trauma caused on the frontlines, as health systems rushed to care for their communities, stressed an already high level of provider and nurse burnout. The pandemic taught us that consumers want convenience and choice, and that health systems need controls to manage the supply of care – DexCare delivers both. “We’re staring at a new era of care delivery,” said Streat, “and this financing validates DexCare’s impact to modernize health commerce, from how care is accessed and orchestrated to deliver. With the backing of our investors, partners, and customers, we’re overhauling an antiquated industry to ensure patients are matched to the right provider, at the right ti...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Adyen Caroline Xie Datadog Define Ventures Derek Streat DexCare Frist Cressey Ventures GitLab Health IT Funding Health IT Fundings Health IT Investment ICONIQ Growth Kaiser Permanente Ventures Source Type: blogs